Topic
Energy & Performance
Quick answers
- What is it?
- This hub covers what research says about building and keeping muscle, strength, and physical performance over a lifetime — everyday nutrition and training approaches (protein, creatine, HMB, collagen, vitamin D, resistance training, blood flow restriction) alongside hormone-based and growth-hormone-secretagogue peptides (CJC-1295, GHRP-2, GHRP-6, hexarelin, IGF-1 LR3, MK-677, MOTS-c, sermorelin, SS-31) and the cognitive effects of creatine and caffeine.
- Why are people interested in it?
- People want to know whether the supplements, training methods, and unregulated 'research peptides' marketed for staying strong, lean, and sharp with age are actually backed by human evidence, or mostly hype extrapolated from animal studies.
- What has actually been studied?
- Sources include randomized controlled trials and meta-analyses on protein intake and timing, creatine, HMB, collagen peptides, vitamin D, testosterone, resistance training, and blood flow restriction, in populations ranging from young athletes to nonagenarians and people losing weight on GLP-1 drugs, alongside clinical-trial registry reviews of nine growth-hormone-secretagogue and mitochondria-targeting peptides.
- How strong is the evidence?
- Evidence is uneven across this hub: resistance training, total protein intake, and creatine (in younger and general populations) rest on dozens of pooled trials, while most growth-hormone-secretagogue peptides marketed for muscle and anti-aging have little or no human trial data — several (ipamorelin, CJC-1295, GHRP-2, hexarelin, IGF-1 LR3, MOTS-c) have never been tested in humans for muscle or aging outcomes at all, and the two most extensively studied compounds in the class, MK-677 and SS-31, have repeatedly failed to show the clinical benefit their biomarker changes suggested.
- What don't we know yet?
- Left unresolved across this hub: whether resistance training or protein specifically preserves muscle during GLP-1-drug weight loss, whether most growth-hormone secretagogues do anything for human muscle at all beyond raising hormone levels, why creatine and testosterone effects differ by age and sex, and whether gains measured on a scan or blood test (IGF-1, lean mass) translate into real-world strength, function, or longevity.
- Where can I read the original research?
- See the individual articles on protein, creatine, resistance training, testosterone, and blood flow restriction, and the peptide profiles for CJC-1295, GHRP-2, GHRP-6, hexarelin, IGF-1 LR3, MK-677, MOTS-c, sermorelin, and SS-31, for the full study-by-study evidence behind each summary here.
Growth hormone secretagogues, creatine, protein timing, resistance training in older adults. The human evidence here is uneven: some questions have dozens of trials, others have a single small study. This hub separates the two.
Peptides in the Evidence Index
Research on this topic
Video briefs
Frequently asked
Do growth hormone secretagogue peptides like CJC-1295, GHRP-2, GHRP-6, hexarelin, and MK-677 actually build muscle?
Mostly untested for that purpose. Ipamorelin and CJC-1295 have never been tested in a human trial for muscle, strength, or aging outcomes — the only completed trials of these compounds looked at gut motility after surgery or HIV-related fat loss, and the only muscle-relevant evidence is a single mouse study. GHRP-2's only human use is a single diagnostic injection to test pituitary function, and GHRP-6's largest human trials tested it combined with a growth factor for stroke, missing its primary endpoint. MK-677 reliably raises growth hormone and IGF-1 and increased lean mass in a 2-year trial of older adults, but that same trial found no improvement in strength or physical function, plus a rise in blood sugar. Across this whole drug class, researchers found these compounds move hormone levels in blood; what that does for muscle in aging humans specifically is mostly untested or unproven.
Does creatine still work for muscle after age 50?
Yes, but with real limits. A 2025 meta-analysis of 69 trials and 1,937 participants found creatine plus resistance training significantly increased squat strength (+5.64 kg) and bench/chest press strength (+1.43 kg) versus placebo, but when split by age, those gains were significant in younger adults and not in older adults. Separate trials in frail or postmenopausal older women found creatine added nothing measurable on top of resistance training alone, and two years of daily creatine did not improve bone density in 200 postmenopausal women. Researchers describe the effect after 50 as smaller, less consistent, and more dependent on simultaneous resistance training than in younger adults.
Does protein timing matter, or is total daily intake what counts?
Controlled trials that held total protein fixed and only changed how it was spread across the day found no muscle or strength benefit to spreading it out — an 8-week resistance-training trial found no significant difference between eating high-protein meals 3 versus 5 times a day, and a 9-day feeding trial found no difference in muscle protein synthesis across four meal-distribution patterns. A separate trial that instead varied the total daily amount, while holding meal pattern fixed, found a higher total dose (1.5 g/kg/day) produced significantly better whole-body protein balance than a lower one (0.8 g/kg/day). Large observational studies are more mixed on this question, with some tying meal-by-meal frequency to muscle and strength.
What is blood flow restriction (BFR) training, and does it actually work?
BFR training uses an inflatable cuff on a limb to partially restrict blood flow during low-load exercise, typically at 20-40% of a person's one-repetition maximum, to try to trigger the metabolic stress normally associated with heavy loads. A meta-analysis of 10 randomized trials in athletes found BFR combined with resistance training produced meaningful gains in lower-limb strength and muscle size compared with conventional training, and head-to-head trials found low-load BFR can match or nearly match heavy-load training for muscle growth and some performance measures. It has not been shown to improve sport-specific performance beyond conventional training, and one trial found inflating BFR cuffs on older adults' legs acutely worsened their walking balance, with worse effects at higher cuff pressure.
Does caffeine actually improve cognitive performance?
Under genuine sleep deprivation and stress, yes: in 68 Navy SEAL trainees after 72 hours without sleep, 200-300 mg of caffeine significantly improved vigilance, choice reaction time, and learning, in a dose-dependent way. But in everyday, non-extreme settings, much of caffeine's apparent 'boost' may be withdrawal reversal rather than true enhancement — one trial found caffeine improved mood and performance only in habitual coffee drinkers who'd gone without it overnight, not in non-consumers, while a separate similarly designed trial found benefits in both groups, so the two controlled studies disagree. A 2010 Cochrane review of 13 trials found caffeine improved memory, attention, and perception scores but had no effect on verbal functioning and language skills.
Does resistance training still work for building strength after 60, or even in your 90s?
Yes. In one of the earliest controlled trials, ten nursing-home residents averaging 90 years old gained 174% in knee-extensor strength after just 8 weeks of high-intensity training, though muscle size grew far less than strength did. Later meta-analyses of dozens of trials confirm resistance training reliably improves strength and muscle mass in older adults, including those with sarcopenia. But training after 60 isn't identical to training at 25 — a lab study found the cellular signaling that converts a workout into new muscle protein activated in younger muscle after exercise and failed to activate, on the same tests, in older muscle, and not every physical-function outcome, like gait speed, improves as reliably as strength does.
New to this?
Start here for plain-English explanations of clinical trials, evidence levels, and how to read a study.